Karyopharm Therapeutics Inc. - Common Stock (KPTI)

9.8850
+1.3050 (15.21%)
NASDAQ · Last Trade: Feb 17th, 3:32 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Registration Momentum Builds Across the Oncology Pipeline
Issued on behalf of Oncolytics Biotech Inc.
By USA News Group · Via GlobeNewswire · February 17, 2026